In the News
FEBRUARY 2021
23 February 2021 – Patrys Achieves Major Development Milestone
DECEMBER 2020
18 December 2020 – Patrys’ PAT-DX1 Hijacks a Nucleoside Transporter to Cross Cell Membranes
SEPTEMBER 2020
30 September 2020 – Major Cancer Deals in DNA Damage Repair
9 September 2020 – Understanding the Blood Brain Barrier (BBB)
8 September 2020 – Janssen Shows Interest in SLE Antibodies
JULY 2020
22 July 2020 – Patrys -Synthetic Lethality to Kill Cancer Cells
APRIL 2020
22 April 2020 – DDR Therapeutics and Synthetic Lethality a Precise Way to Kill Cancer Cells
20 April 2020 – Exploiting the DNA Damage Response Pathway to Treat Cancer
OCTOBER 2018
19 October 2018 – Patrys Selects Indications for Unique Cancer Treatment Approach
SEPTEMBER 2018
10 September 2017 – Nuclear-penetrating DNA binding antibodies as cancer therapies
SEPTEMBER 2017
14 September 2017 – Aussie cancer drug developer jumps 400pc after human tissue tests